We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AXON Q2 EPS of $2.12 beat estimates by 58 cents, with revenues up 33% to $668.5M on strong product demand.
Connected Devices revenues rose 28.6%, while Software and Service jumped 38.8% with margin expansion to 78.9%.
AXON raised 2025 revenue guidance to $2.65-$2.73B, targeting 29% growth and $665-$685M in adjusted EBITDA.
Axon Enterprise, Inc. (AXON - Free Report) reported second-quarter 2025 adjusted earnings of $2.12 per share, which surpassed the Zacks Consensus Estimate of $1.54. The bottom line surged 73.8% year over year despite a rise in the cost of sales.
Total revenues of $668.5 million surpassed the consensus estimate of $643 million and increased 33% year over year. The top line benefited from strong demand for TASER 10, Axon Body 4 and counter-drone equipment. Growing adoption of premium software solutions also augmented the top-line results.
AXON’s Q2 Business Segment Performance
Effective first-quarter 2025, AXON realigned its business segments. The company now reports results under two business segments, namely Connected Devices and Software & Services.
Connected Devices: The segment’s revenues jumped 28.6% year over year to $376.4 million, driven by increase in demand for TASER 10 devices and associated cartridges, and Axon Body 4 as well as growth in platform solutions. The adjusted gross margin decreased year over year to 51.1% from 53.4%. The Zacks Consensus Estimate for Connected Devices’ revenues was pegged at $366 million.
Software & Services: The segment’s revenues rose 38.8% year over year to $292.2 million. The uptick was driven by an increase in the aggregate number of users and growing adoption of premium software offerings. The adjusted gross margin increased to 78.9% from 76. 6% in the year-ago period due to a higher software mix. The Zacks Consensus Estimate for Software & Services’ revenues was pegged at $284 million.
Axon Enterprise, Inc Price, Consensus and EPS Surprise
Axon’s cost of sales increased 11.3% year over year to $264.8 million. Selling, general and administrative expenses increased 8.4% year over year to $242.2 million.
Total operating expenses climbed 8.1% year over year to $404.8 million. The adjusted gross margin increased to 63.3% from 63.1% in the year-ago period.
AXON’s Balance Sheet & Cash Flow
At the end of second-quarter 2025, Axon had cash and cash equivalents of $615.5 million compared with $454.8 million at December 2024-end. Long-term lease liabilities totaled $43.6 million compared with $41.4 million at 2024-end.
In the first six months of 2025, the company used net cash of $65.9 million from operating activities against $66.8 million in cash generated in the previous year period.
Adjusted free cash flow was a negative $113.7 million in the first six months of 2025 compared with $39.3 million in the prior-year period.
AXON’s Outlook for 2025
For 2025, Axon expects revenues to be in the band of $2.65-$2.73 billion compared with $2.60-$2.70 billion anticipated earlier. The metric indicates approximately 29% year-over-year growth at the midpoint. Adjusted EBITDA is expected to be in the range of $665-$685 million, implying an adjusted EBITDA margin of about 25%.
The company expects capital expenditures to be between $170 million and $185 million. This includes investments in long-term research & development projects, continued capacity expansion, global facility build-outs and new product development. It anticipates stock-based compensation expenses to be in the range of $580-$630 million.
Some other top-ranked companies are discussed below:
TransDigm Group Incorporated (TDG - Free Report) presently carries a Zacks Rank #2 (Buy). TDG’s earnings surpassed the consensus estimate in each of the trailing four quarters. The average earnings surprise was 5.1%. In the past 60 days, the Zacks Consensus Estimate for Transdigm’s 2025 earnings has inched up 0.2%.
Woodward, Inc. (WWD - Free Report) currently carries a Zacks Rank of 2. WWD has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 15%. In the past 60 days, the Zacks Consensus Estimate for Woodward’s fiscal 2025 (ending September 2025) earnings has increased 3.4%.
HEICO Corporation (HEI - Free Report) currently carries a Zacks Rank of 2. HEI outperformed the consensus estimate in each of the preceding four quarters, with an average surprise of 11.9%. In the past 60 days, the Zacks Consensus Estimate for HEICO’s 2025 earnings has increased 2%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Axon Tops Q2 Earnings & Revenue Estimates, Raises 2025 Guidance
Key Takeaways
Axon Enterprise, Inc. (AXON - Free Report) reported second-quarter 2025 adjusted earnings of $2.12 per share, which surpassed the Zacks Consensus Estimate of $1.54. The bottom line surged 73.8% year over year despite a rise in the cost of sales.
Total revenues of $668.5 million surpassed the consensus estimate of $643 million and increased 33% year over year. The top line benefited from strong demand for TASER 10, Axon Body 4 and counter-drone equipment. Growing adoption of premium software solutions also augmented the top-line results.
AXON’s Q2 Business Segment Performance
Effective first-quarter 2025, AXON realigned its business segments. The company now reports results under two business segments, namely Connected Devices and Software & Services.
Connected Devices: The segment’s revenues jumped 28.6% year over year to $376.4 million, driven by increase in demand for TASER 10 devices and associated cartridges, and Axon Body 4 as well as growth in platform solutions. The adjusted gross margin decreased year over year to 51.1% from 53.4%. The Zacks Consensus Estimate for Connected Devices’ revenues was pegged at $366 million.
Software & Services: The segment’s revenues rose 38.8% year over year to $292.2 million. The uptick was driven by an increase in the aggregate number of users and growing adoption of premium software offerings. The adjusted gross margin increased to 78.9% from 76. 6% in the year-ago period due to a higher software mix. The Zacks Consensus Estimate for Software & Services’ revenues was pegged at $284 million.
Axon Enterprise, Inc Price, Consensus and EPS Surprise
Axon Enterprise, Inc price-consensus-eps-surprise-chart | Axon Enterprise, Inc Quote
AXON’s Margin Profile
Axon’s cost of sales increased 11.3% year over year to $264.8 million. Selling, general and administrative expenses increased 8.4% year over year to $242.2 million.
Total operating expenses climbed 8.1% year over year to $404.8 million. The adjusted gross margin increased to 63.3% from 63.1% in the year-ago period.
AXON’s Balance Sheet & Cash Flow
At the end of second-quarter 2025, Axon had cash and cash equivalents of $615.5 million compared with $454.8 million at December 2024-end. Long-term lease liabilities totaled $43.6 million compared with $41.4 million at 2024-end.
In the first six months of 2025, the company used net cash of $65.9 million from operating activities against $66.8 million in cash generated in the previous year period.
Adjusted free cash flow was a negative $113.7 million in the first six months of 2025 compared with $39.3 million in the prior-year period.
AXON’s Outlook for 2025
For 2025, Axon expects revenues to be in the band of $2.65-$2.73 billion compared with $2.60-$2.70 billion anticipated earlier. The metric indicates approximately 29% year-over-year growth at the midpoint. Adjusted EBITDA is expected to be in the range of $665-$685 million, implying an adjusted EBITDA margin of about 25%.
The company expects capital expenditures to be between $170 million and $185 million. This includes investments in long-term research & development projects, continued capacity expansion, global facility build-outs and new product development. It anticipates stock-based compensation expenses to be in the range of $580-$630 million.
AXON’s Zacks Rank & Other Key Picks
The company currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Some other top-ranked companies are discussed below:
TransDigm Group Incorporated (TDG - Free Report) presently carries a Zacks Rank #2 (Buy). TDG’s earnings surpassed the consensus estimate in each of the trailing four quarters. The average earnings surprise was 5.1%. In the past 60 days, the Zacks Consensus Estimate for Transdigm’s 2025 earnings has inched up 0.2%.
Woodward, Inc. (WWD - Free Report) currently carries a Zacks Rank of 2. WWD has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 15%. In the past 60 days, the Zacks Consensus Estimate for Woodward’s fiscal 2025 (ending September 2025) earnings has increased 3.4%.
HEICO Corporation (HEI - Free Report) currently carries a Zacks Rank of 2. HEI outperformed the consensus estimate in each of the preceding four quarters, with an average surprise of 11.9%. In the past 60 days, the Zacks Consensus Estimate for HEICO’s 2025 earnings has increased 2%.